Decreased Expression of CXCR4 Chemokine Receptor in Bone Marrow after Chemotherapy in Patients with Non-Hodgkin Lymphomas Is a Good Prognostic Factor. The gene discussed is CXCR4; the disease is non-Hodgkin lymphoma.